1Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCICURE study. Lancet, 2001,358:527-533. 被引量：1
2Sabatine MS, Cannon CP, Gibson CM, et al. Addition of elopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med, 2005, 352:1179-1189. 被引量：1
3Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet, 2005,366 : 1607-1621. 被引量：1
4Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J, 2005, 26:804-847. 被引量：1
5Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001,345:494-502. 被引量：1
6Eikelboom JW, Hirsh J. Bleeding and management of bleeding. Eur Heart J, 2006,8 (Suppl G):G38-G45. 被引量：1
7Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA, 2004, 292:1555-1562. 被引量：1
8Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation, 2006, 114 : 774-782. 被引量：1
9Wallis JP. Nitric oxide and blood: a review. Transfus Med, 2005, 15:1-11. 被引量：1
10Yang X, Alexander KP, Chen AY, et al. The implications of blood transfusions for patients with non- ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol, 2005, 46: 1490-1495. 被引量：1
